Appellate Court Gives PhRMA’s IRA Argument A Chance

Appellate Court Gives PhRMA’s IRA Argument A Chance

Published On: 09/22/2024Tags: Agencies, Biopharma, Cell and Gene Therapy, Clinical Labs, Courts, Drug Reform/Pricing